| 000 | 01165 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514031601.0 | ||
| 264 | 0 | _c20050628 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a1526-8209 | ||
| 024 | 7 |
_a10.3816/cbc.2000.s.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVerheul, H M | |
| 245 | 0 | 0 |
_aThe role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitors. _h[electronic resource] |
| 260 |
_bClinical breast cancer _cSep 2000 |
||
| 300 |
_aS80-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasm Metastasis _xphysiopathology |
| 650 | 0 | 4 |
_aNeoplasms _xphysiopathology |
| 650 | 0 | 4 | _aNeovascularization, Pathologic |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xpharmacology |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-1 _xphysiology |
| 700 | 1 | _aPinedo, H M | |
| 773 | 0 |
_tClinical breast cancer _gvol. 1 Suppl 1 _gp. S80-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3816/cbc.2000.s.015 _zAvailable from publisher's website |
| 999 |
_c11872315 _d11872315 |
||